_id
691482b4ccc777a4e85d93dd
Ticker
NMRA
Name
Neumora Therapeutics, Inc.
Exchange
NASDAQ
Address
490 Arsenal Way, Watertown, MA, United States, 02472
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.neumoratx.com
Description
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease. In addition, the company's preclinical phase product includes NMRA-NMDA and NMRA-M4R for the treatment of Schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.
Last Close
1.81
Volume
1982376
Current Price
2.22
Change
-0.13
Last Updated
2026-01-05T11:30:48.569Z
Image
data:image/webp;base64,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
Ipo Date
2023-09-14T00:00:00.000Z
Market Cap
282097824
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9944999999999999
Sentiment Sources
2
Rating
3.5
Target Price
9.1667
Strong Buy
1
Buy
2
Hold
5
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
5000000
Gross Profit
-5000000
Operating Expenses
52700000
Operating Income
-57700000
Interest Expense
747000
Pretax Income
-56755000
Net Income
-56755000
Eps
-0.35069019636920873
Dividends Per Share
-
Shares Outstanding
169938441
Income Tax Expense
-
EBITDA
-55985000
Operating Margin
-
Total Other Income Expense Net
945000
Cash
129071000
Short Term Investments
42454000
Receivables
-
Inventories
-
Total Current Assets
177082000
Property Plant Equipment
554000
Total Assets
177833000
Payables
549000
Short Term Debt
256000
Long Term Debt
19563000
Total Liabilities
45672000
Equity
132161000
Bs_currency_symbol
USD
Depreciation
23000
Change In Working Capital
4483000
Cash From Operations
-46633000
Capital Expenditures
16000
Cash From Investing
51317000
Cash From Financing
-136000
Net Change In Cash
4548000
Cf_currency_symbol
USD
PE
-
PB
2.7185051565893117
ROE
-42.943833657432975
ROA
-31.914773973334533
FCF
-46649000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
1.5
Quality Investing Score
2.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
5000000
Quarters > 0 > income Statement > gross Profit
-5000000
Quarters > 0 > income Statement > operating Expenses
52700000
Quarters > 0 > income Statement > operating Income
-57700000
Quarters > 0 > income Statement > interest Expense
747000
Quarters > 0 > income Statement > pretax Income
-56755000
Quarters > 0 > income Statement > net Income
-56755000
Quarters > 0 > income Statement > eps
-0.35069019636920873
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
161838000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-55985000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
945000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
129071000
Quarters > 0 > balance Sheet > short Term Investments
42454000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
177082000
Quarters > 0 > balance Sheet > property Plant Equipment
554000
Quarters > 0 > balance Sheet > total Assets
177833000
Quarters > 0 > balance Sheet > payables
549000
Quarters > 0 > balance Sheet > short Term Debt
256000
Quarters > 0 > balance Sheet > long Term Debt
19563000
Quarters > 0 > balance Sheet > total Liabilities
45672000
Quarters > 0 > balance Sheet > equity
132161000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-56755000
Quarters > 0 > cash Flow > depreciation
23000
Quarters > 0 > cash Flow > change In Working Capital
4483000
Quarters > 0 > cash Flow > cash From Operations
-46633000
Quarters > 0 > cash Flow > capital Expenditures
16000
Quarters > 0 > cash Flow > cash From Investing
51317000
Quarters > 0 > cash Flow > cash From Financing
-136000
Quarters > 0 > cash Flow > net Change In Cash
4548000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.35069019636920873
Quarters > 0 > ratios > PB
2.7185051565893117
Quarters > 0 > ratios > ROE
-42.943833657432975
Quarters > 0 > ratios > ROA
-31.914773973334533
Quarters > 0 > ratios > FCF
-46649000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
54040000
Quarters > 1 > income Statement > operating Income
-54040000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-52706000
Quarters > 1 > income Statement > net Income
-52731000
Quarters > 1 > income Statement > eps
-0.3261220476093289
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
161691000
Quarters > 1 > income Statement > income Tax Expense
25000
Quarters > 1 > income Statement > EBITDA
-54021000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
1334000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
124523000
Quarters > 1 > balance Sheet > short Term Investments
93065000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
222909000
Quarters > 1 > balance Sheet > property Plant Equipment
618000
Quarters > 1 > balance Sheet > total Assets
223825000
Quarters > 1 > balance Sheet > payables
644000
Quarters > 1 > balance Sheet > short Term Debt
171000
Quarters > 1 > balance Sheet > long Term Debt
19451000
Quarters > 1 > balance Sheet > total Liabilities
40946000
Quarters > 1 > balance Sheet > equity
182879000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-52731000
Quarters > 1 > cash Flow > depreciation
19000
Quarters > 1 > cash Flow > change In Working Capital
-7604000
Quarters > 1 > cash Flow > cash From Operations
-52404000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
30397000
Quarters > 1 > cash Flow > cash From Financing
18457000
Quarters > 1 > cash Flow > net Change In Cash
-3550000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.3261220476093289
Quarters > 1 > ratios > PB
1.96279518151346
Quarters > 1 > ratios > ROE
-28.83381908256279
Quarters > 1 > ratios > ROA
-23.559030492572322
Quarters > 1 > ratios > FCF
-52404000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
70936000
Quarters > 2 > income Statement > operating Income
-70936000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-67887000
Quarters > 2 > income Statement > net Income
-67992000
Quarters > 2 > income Statement > eps
-0.421130869427876
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
161451000
Quarters > 2 > income Statement > income Tax Expense
105000
Quarters > 2 > income Statement > EBITDA
-70779000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
3049000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
126860000
Quarters > 2 > balance Sheet > short Term Investments
122493000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
254866000
Quarters > 2 > balance Sheet > property Plant Equipment
1882000
Quarters > 2 > balance Sheet > total Assets
256748000
Quarters > 2 > balance Sheet > payables
1052000
Quarters > 2 > balance Sheet > short Term Debt
938000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
28384000
Quarters > 2 > balance Sheet > equity
228364000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-67992000
Quarters > 2 > cash Flow > depreciation
157000
Quarters > 2 > cash Flow > change In Working Capital
-525000
Quarters > 2 > cash Flow > cash From Operations
-59448000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
44160000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-15288000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.421130869427876
Quarters > 2 > ratios > PB
1.5695171743357097
Quarters > 2 > ratios > ROE
-29.773519468918042
Quarters > 2 > ratios > ROA
-26.481997912349854
Quarters > 2 > ratios > FCF
-59448000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
43
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
318000
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
62922000
Quarters > 3 > income Statement > operating Income
-62922000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-58819000
Quarters > 3 > income Statement > net Income
-58819000
Quarters > 3 > income Statement > eps
-0.36537171395915125
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
160984000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-62765000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
4103000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
142148000
Quarters > 3 > balance Sheet > short Term Investments
165430000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
314055000
Quarters > 3 > balance Sheet > property Plant Equipment
2917000
Quarters > 3 > balance Sheet > total Assets
316972000
Quarters > 3 > balance Sheet > payables
3307000
Quarters > 3 > balance Sheet > short Term Debt
1853000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
29908000
Quarters > 3 > balance Sheet > equity
287064000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-58819000
Quarters > 3 > cash Flow > depreciation
157000
Quarters > 3 > cash Flow > change In Working Capital
-1356000
Quarters > 3 > cash Flow > cash From Operations
-50340000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-98799000
Quarters > 3 > cash Flow > cash From Financing
15573000
Quarters > 3 > cash Flow > net Change In Cash
-133566000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.36537171395915125
Quarters > 3 > ratios > PB
1.2449644678538585
Quarters > 3 > ratios > ROE
-20.48985592063094
Quarters > 3 > ratios > ROA
-18.556528652373082
Quarters > 3 > ratios > FCF
-50340000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
43
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
263464000
Annuals > 0 > income Statement > operating Income
-263464000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-243609000
Annuals > 0 > income Statement > net Income
-243787000
Annuals > 0 > income Statement > eps
-1.5296247262779448
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
159377000
Annuals > 0 > income Statement > income Tax Expense
178000
Annuals > 0 > income Statement > EBITDA
-262833000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
19855000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
142148000
Annuals > 0 > balance Sheet > short Term Investments
165430000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
314055000
Annuals > 0 > balance Sheet > property Plant Equipment
2917000
Annuals > 0 > balance Sheet > total Assets
316972000
Annuals > 0 > balance Sheet > payables
3307000
Annuals > 0 > balance Sheet > short Term Debt
1853000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
29908000
Annuals > 0 > balance Sheet > equity
287064000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-243787000
Annuals > 0 > cash Flow > depreciation
631000
Annuals > 0 > cash Flow > change In Working Capital
22636000
Annuals > 0 > cash Flow > cash From Operations
-182936000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-70557000
Annuals > 0 > cash Flow > cash From Financing
21603000
Annuals > 0 > cash Flow > net Change In Cash
-231890000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.5296247262779448
Annuals > 0 > ratios > PB
0.9216266059136639
Annuals > 0 > ratios > ROE
-84.92426775910599
Annuals > 0 > ratios > ROA
-76.91120982294967
Annuals > 0 > ratios > FCF
-182936000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
668000
Annuals > 1 > income Statement > gross Profit
-668000
Annuals > 1 > income Statement > operating Expenses
187526000
Annuals > 1 > income Statement > operating Income
-188194000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-235657000
Annuals > 1 > income Statement > net Income
-235925000
Annuals > 1 > income Statement > eps
-1.485374483731238
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
158832000
Annuals > 1 > income Statement > income Tax Expense
268000
Annuals > 1 > income Statement > EBITDA
-187526000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-47463000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
374038000
Annuals > 1 > balance Sheet > short Term Investments
79944000
Annuals > 1 > balance Sheet > receivables
939000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
478279000
Annuals > 1 > balance Sheet > property Plant Equipment
6858000
Annuals > 1 > balance Sheet > total Assets
496195000
Annuals > 1 > balance Sheet > payables
337000
Annuals > 1 > balance Sheet > short Term Debt
3378000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
27119000
Annuals > 1 > balance Sheet > equity
469076000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-235925000
Annuals > 1 > cash Flow > depreciation
668000
Annuals > 1 > cash Flow > change In Working Capital
-8899000
Annuals > 1 > cash Flow > cash From Operations
-163278000
Annuals > 1 > cash Flow > capital Expenditures
117000
Annuals > 1 > cash Flow > cash From Investing
64387000
Annuals > 1 > cash Flow > cash From Financing
231936000
Annuals > 1 > cash Flow > net Change In Cash
133045000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.485374483731238
Annuals > 1 > ratios > PB
0.5620861438231758
Annuals > 1 > ratios > ROE
-50.295687692399525
Annuals > 1 > ratios > ROA
-47.54683138685396
Annuals > 1 > ratios > FCF
-163395000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
2697000
Annuals > 2 > income Statement > gross Profit
-2697000
Annuals > 2 > income Statement > operating Expenses
135870000
Annuals > 2 > income Statement > operating Income
-135870000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-130904000
Annuals > 2 > income Statement > net Income
-130904000
Annuals > 2 > income Statement > eps
-0.8614990378093463
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
151949096
Annuals > 2 > income Statement > income Tax Expense
-4561000
Annuals > 2 > income Statement > EBITDA
-135276000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
4966000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
240943000
Annuals > 2 > balance Sheet > short Term Investments
130941000
Annuals > 2 > balance Sheet > receivables
919000
Annuals > 2 > balance Sheet > inventories
50000
Annuals > 2 > balance Sheet > total Current Assets
387955000
Annuals > 2 > balance Sheet > property Plant Equipment
10642000
Annuals > 2 > balance Sheet > total Assets
426234000
Annuals > 2 > balance Sheet > payables
7147000
Annuals > 2 > balance Sheet > short Term Debt
3370000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
873084000
Annuals > 2 > balance Sheet > equity
-446850000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-130904000
Annuals > 2 > cash Flow > depreciation
594000
Annuals > 2 > cash Flow > change In Working Capital
-6948000
Annuals > 2 > cash Flow > cash From Operations
-114896000
Annuals > 2 > cash Flow > capital Expenditures
511000
Annuals > 2 > cash Flow > cash From Investing
-168013000
Annuals > 2 > cash Flow > cash From Financing
115743000
Annuals > 2 > cash Flow > net Change In Cash
-167166000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.8614990378093463
Annuals > 2 > ratios > PB
-0.564474654492559
Annuals > 2 > ratios > ROE
29.294841669464027
Annuals > 2 > ratios > ROA
-30.71176865289958
Annuals > 2 > ratios > FCF
-115407000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1551000
Annuals > 3 > income Statement > gross Profit
-1551000
Annuals > 3 > income Statement > operating Expenses
237323000
Annuals > 3 > income Statement > operating Income
-237323000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-237312000
Annuals > 3 > income Statement > net Income
-237312000
Annuals > 3 > income Statement > eps
-1.561786191870467
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
151949096
Annuals > 3 > income Statement > income Tax Expense
301442
Annuals > 3 > income Statement > EBITDA
-236785000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
11000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
409247000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
200000
Annuals > 3 > balance Sheet > inventories
125000
Annuals > 3 > balance Sheet > total Current Assets
415603000
Annuals > 3 > balance Sheet > property Plant Equipment
4041000
Annuals > 3 > balance Sheet > total Assets
429297000
Annuals > 3 > balance Sheet > payables
1639000
Annuals > 3 > balance Sheet > short Term Debt
1056000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
754518000
Annuals > 3 > balance Sheet > equity
-325221000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-237312000
Annuals > 3 > cash Flow > depreciation
538000
Annuals > 3 > cash Flow > change In Working Capital
-961000
Annuals > 3 > cash Flow > cash From Operations
-75420000
Annuals > 3 > cash Flow > capital Expenditures
817000
Annuals > 3 > cash Flow > cash From Investing
-817000
Annuals > 3 > cash Flow > cash From Financing
293507000
Annuals > 3 > cash Flow > net Change In Cash
217270000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.561786191870467
Annuals > 3 > ratios > PB
-0.7755818331534556
Annuals > 3 > ratios > ROE
72.96945769184646
Annuals > 3 > ratios > ROA
-55.27921229358695
Annuals > 3 > ratios > FCF
-76237000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.35069019636920873
Valuation > metrics > PB
2.7185051565893117
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-42.943833657432975
Profitability > metrics > ROA
-32.05012367151941
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3455784989520358
Risk > metrics > Interest Coverage
-77.24230254350736
Risk > final Score
-249
Risk > verdict
High
Liquidity > metrics > Current Ratio
219.9776397515528
Liquidity > metrics > Quick Ratio
219.9776397515528
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-104
Prev Risks > 1
-38
Prev Risks > 2
-4
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:17:20.831Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-29
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.35
Earnings History > 0 > eps Estimate
-0.45
Earnings History > 0 > eps Difference
0.1
Earnings History > 0 > surprise Percent
22.2222
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.33
Earnings History > 1 > eps Estimate
-0.45
Earnings History > 1 > eps Difference
0.12
Earnings History > 1 > surprise Percent
26.6667
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-13
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.42
Earnings History > 2 > eps Estimate
-0.46
Earnings History > 2 > eps Difference
0.04
Earnings History > 2 > surprise Percent
8.6957
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-03
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.37
Earnings History > 3 > eps Estimate
-0.62
Earnings History > 3 > eps Difference
0.25
Earnings History > 3 > surprise Percent
40.3226
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.45
Earnings History > 4 > eps Estimate
-0.65
Earnings History > 4 > eps Difference
0.2
Earnings History > 4 > surprise Percent
30.7692
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-06
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.37
Earnings History > 5 > eps Estimate
-0.68
Earnings History > 5 > eps Difference
0.31
Earnings History > 5 > surprise Percent
45.5882
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-07
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.34
Earnings History > 6 > eps Estimate
-0.34
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
0
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-07
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.71
Earnings History > 7 > eps Estimate
-0.55
Earnings History > 7 > eps Difference
-0.16
Earnings History > 7 > surprise Percent
-29.0909
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-01
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.14
Earnings History > 8 > eps Estimate
-0.36
Earnings History > 8 > eps Difference
-0.78
Earnings History > 8 > surprise Percent
-216.6667
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.2783
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.2783
Earnings History > 9 > surprise Percent
-
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease. In addition, the company's preclinical phase product includes NMRA-NMDA and NMRA-M4R for the treatment of Schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWilliam Blair Maintains Neumora Therapeutics(NMRA.US) With Hold Rating 富途资讯
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$9.1667
Analyst Picks
Strong Buy
1
Buy
2
Hold
5
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Neumora Therapeutics, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.35
EPS Estimate
-0.45
EPS Difference
0.1
Surprise Percent
22.2222%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.